As regenerative aesthetics continues its growth trajectory, exosomes are emerging as an exciting tool in skin rejuvenation. But not all exosomes are the same, and understanding the differences is key to clinical decision-making.
Acting as tiny biological couriers, exosomes have captured the attention of the aesthetic and greater medical community. These naturally occurring nanovesicles – produced by cells to transfer biological signals – are showing promise in helping skin recover, regenerate and revitalise, and as portals for cell-free drug delivery systems. With applications ranging from post-treatment recovery to general skin rejuvenation and hair restoration, exosome-based therapies are emerging as a modality worth further exploration.
As the science evolves, so too does the understanding that exosomes vary in their origin, composition and function. For practitioners, knowing what type of exosome is in a formulation and what it can realistically achieve is important for treatment planning, patient education and optimal outcomes.
How exosomes work
Exosomes are nanosized extracellular vesicles – typically 30 to 150 nanometres in diameter – naturally released by most cell types as part of the body’s cellular communication system. Once considered cellular waste, they are now recognised as biologically active messengers.
They transport functional cargo such as proteins, lipids, mRNA, and microRNA to neighbouring or distant cells, influencing their behaviour and playing key roles in processes including tissue regeneration, immune modulation and inflammatory signalling.
Cellular communication
Exosomes play a central role in intercellular signalling. They facilitate communication between cells by transporting bioactive cargo that can influence how recipient cells behave. In skin, this signalling can support tissue repair, modulate inflammatory responses and regulate extracellular matrix remodelling.
Stimulating regeneration
Exosomes derived from sources such as mesenchymal stem cells or human platelets carry regenerative proteins and RNA that may stimulate dermal fibroblasts, enhance collagen and elastin production, and accelerate wound healing. These effects are particularly relevant in aesthetic medicine, where exosomes are being explored as adjuncts to energy- based treatments, microneedling and post-surgical recovery.
Enhanced delivery potential
When applied topically after procedures that temporarily disrupt the skin barrier – such as microneedling, laser or radiofrequency – exosomes may penetrate more effectively into deeper layers of the skin. This enhanced delivery supports their ability to interact with dermal cells and optimise treatment outcomes. Some formulations are specifically designed for use in conjunction with these procedures to maximise regenerative signalling during the skin’s natural repair window.
As research continues, exosomes are being investigated not only for their regenerative potential but also for their role in skin quality maintenance, barrier recovery and adjunctive care across a variety of aesthetic indications.
3 main types of exosomes used in aesthetics
In aesthetic medicine, exosome- based technologies most commonly fall into three categories based on their source: mesenchymal stem cells, platelets and plants. Each type differs in biological composition, signalling capability and potential clinical application.
1. Mesenchymal stem cell- derived exosomes (MSCs)
- Origin: Human mesenchymal stem cells (eg, bone marrow, adipose, umbilical cord)
- Structure: Contains cytokines, growth factors, microRNA, RNA, lipids
- Clinical potential: Post-procedure recovery, collagen stimulation, anti- inflammatory support
MSC-derived exosomes are obtained from cultured human mesenchymal stem cells, commonly sourced from bone marrow, adipose tissue or umbilical cord tissue. These exosomes contain a broad range of signalling molecules, including cytokines, growth factors, mRNA and microRNA. They have been studied for their role in modulating inflammation, promoting angiogenesis, supporting extracellular matrix remodelling and enhancing wound healing. In aesthetic medicine, MSC-derived exosomes are typically applied topically after energy-based treatments or microneedling to support skin recovery and rejuvenation. Manufacturing methods, source material and purification protocols vary between products and can influence consistency and activity.
2. Platelet-derived exosomes
- Origin: Human blood platelets, purified into vesicles
- Structure: Platelet-derived growth factors, signalling proteins, RNA fragments
- Clinical potential: Accelerating recovery, improving skin quality, scar and texture refinement
These exosomes are derived from human platelet concentrate and are typically isolated through proprietary processing techniques. Platelets naturally contain a high concentration of growth factors and regenerative proteins involved in wound healing. Exosomes isolated from platelets retain many of these bioactive components, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β) and vascular endothelial growth factor (VEGF), among others.
In clinical use, platelet-derived exosomes are applied to skin after procedures such as laser resurfacing, chemical peels or surgery to support healing and reduce post-treatment downtime.
3. Plant-derived exosomes
- Origin: Various plants and plant parts
- Structure: Rich in polyphenols, plant metabolites, protective enzymes
- Clinical potential: Topical support for oxidative stress, barrier repair and hydration
Plant-derived exosomes, sometimes referred to as plant extracellular vesicles, are extracted from sources such as green tea, ginseng, carrots and ginger. These vesicles do not contain human signalling molecules but may deliver plant-based compounds such as polyphenols, flavonoids, enzymes and antioxidants. They are being explored for their potential to support skin barrier function and reduce oxidative stress. Plant-derived exosomes are typically incorporated into topical skincare products, including masks and serums, often as part of pre- or post-treatment regimens.
While they do not contain human signalling molecules in the sense of molecules originally produced by human cells, they carry their own plant-derived ‘signals’ that may interact with and influence human cells. This phenomenon, known as cross- kingdom communication, is an active area of medical research.
A growing role in aesthetic protocols
Today, exosomes are increasingly being integrated into aesthetic treatment plans across multiple indications. Key areas include:
- Post-procedure recovery: Exosomes are often used after ablative or fractional laser, RF microneedling and peels to help calm inflammation, reduce redness and improve patient comfort.
- Rejuvenation and anti-ageing: Applied topically, exosomes can support fibroblast activity and collagen production.
- Hair restoration: Emerging data suggests exosomes may support follicle regeneration and improve scalp health when used alongside needling or mesotherapy.
- Pigmentation and barrier repair: Exosomes that modulate inflammation can be helpful in calming pigment-prone skin and supporting skin resilience.
The clinical application of exosomes in aesthetic medicine is still in its early stages. While preclinical data and early studies are encouraging, larger-scale trials and long-term evidence are needed to fully define their efficacy, stability, reproducibility and best-use protocols.
For now, exosomes offer a compelling addition to the evolving regenerative toolkit – one that may continue to shape the future of minimally invasive aesthetic care as the science progresses.
Mayo Clinic case study:
Platelet-derived exosomes in aesthetic care
A May 2025 Mayo Clinic news article highlighted the growing use of human platelet-derived exosomes in facial aesthetic procedures. At the Mayo Clinic Cosmetic Center, these exosomes are now applied topically during surgical and non-surgical treatments to help support skin recovery, improve texture and reduce visible redness.
‘Exosomes can come from many sources,’ the article states. ‘However, when extracted from human platelets, exosomes offer regenerative power that is more reproducible, more reliable and easier to process than exosomes derived from other sources. Exosomes are not “alive” and do not replicate, limiting concerns about possible immune reactions or oncogenesis.’
Mayo Clinic physicians and scientists pioneered the cell-free processing technology used to manufacture these platelet- derived exosomes. They assert the patented method produces a clinical-grade product that is sterile, pure and shelf-stable, enabling consistent dosing and reliable outcomes in a practice setting.
Clinical applications of topical platelet-derived exosomes in aesthetic medicine are supported by an expanding body of evidence. Topical platelet-derived exosomes have been shown to influence several key aspects of skin and hair regeneration.
A 2024 study published in Dermatologic Surgery found that a 12-week application protocol significantly reduced the presence of senescent skin cells, with an associated 40 percent decrease in pro- inflammatory signalling.
Improvements in overall skin quality have also been documented. Imaging data from a six-week study, published in the Aesthetic Surgery Journal, reported visible enhancements in collagen and elastin production and reductions in facial photodamage – attributed to the activity of platelet-derived growth factors.
Exosomes may assist in wound healing and scar management. A 2024 study in Plastic and Reconstructive Surgery – Global Open found that topical application supported faster healing and a reduction in the visible appearance of scars.
Exosomes also show promise in hair restoration: a review in Clinical, Cosmetic and Investigational Dermatology noted that exosomes from various biological sources can stimulate and extend the anagen phase of hair growth.
